在多发性硬化症的临床实践中解决患者报告的认知障碍:具有挑战性的努力
Gabrielle Macaron1,2,3, Nour Farah3, Simon Charbonneau4
1Neurology Department, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
概括
患者报告的认知障碍 (CI) 显著影响多发性硬化症 (MS) 的生活质量. 解决这些问题至关重要,因为可以有效地管理CI的可逆性原因.
科学领域:
- 神经学 神经学
- 神经心理学 神经心理学
背景情况:
- 认知障碍 (CI) 是患有多发性硬化症 (PwMS) 的人群中普遍存在和致残的症状.
- 常规CI评估是具有挑战性的,因为神经心理评估的访问和主观关注的解释有限.
- 在PwMS中客观和主观认知测量之间的关系是复杂的,通常是不一致的.
研究的目的:
- 在PwMS中审查患者报告的CI.
- 强调主观和客观CI指标之间的关联.
- 探索当前CI查中的混因素和局限性.
主要方法:
- 文献综述的重点是多发性硬化症患者报告的认知障碍.
- 分析主观和客观认知措施之间的关联.
- 检查混因素和选方法的局限性.
主要成果:
- 患者报告的CI显著影响PwMS患者的生活质量.
- 主观和客观认知评估之间的不一致是常见的.
- 有效评估和管理患者报告的CI是必不可少的.
结论:
- 患者报告的认知障碍对PwMS的日常生活质量产生了重大影响.
- 需要有效评估患者报告的CI.
- 几种可逆性CI原因可以在检测后有效地管理.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317
Dementia
65
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
65
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Cognitive Development During Adulthood
23
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
23


